SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...
New research suggests that familial risk of Alzheimer's disease may be higher depending on which parent is affected.
A new study provides important insight into how amyloid-beta and tau proteins impact brain activity and possibly contribute to cognitive decline in Alzheimer's disease.
Around 55 million people globally are affected by dementia, with Alzheimer's disease responsible for 70% of these cases. The ...
For years, many people with Alzheimer's disease have been diagnosed clinically and confirmed at autopsy. Now Alzheimer's ...
Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.
Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...
Carmen A. Guzman, 75, was reported missing on Sept. 19 when he was last seen with family at Hardee’s restaurant, 913 E. Main ...
There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...
Optimizing iPSC differentiation significantly improves in vitro Alzheimer's disease models, leading to more accurate and ...
On Sep. 22, 2024 the St. Joe Frontier Casino and the Alzheimer's Association held their annual Walk to End Alzheimer's.